Shanghai Haohai Biological Technology Co., Ltd. issued a Next Day Disclosure Return dated 06 November 2025. According to the announcement, the total number of H shares remains 38,529,240, while 386,900 H shares have been repurchased since 15 September 2025 but not yet cancelled. On 06 November 2025, 27,100 H shares were repurchased on the Hong Kong Stock Exchange at prices ranging from HKD 27.52 to HKD 27.58, for an aggregate consideration of HKD 746,882.

The document also shows that the total number of A shares stands at 190,203,760, with 3,848,095 shares held in treasury. No change was recorded for A shares on 06 November 2025. Under the repurchase mandate dated 10 June 2025, Haohai Biological is authorized to repurchase up to 3,914,184 shares, of which 386,900 shares have been repurchased to date, representing 0.9885% of the issued shares (excluding treasury shares) as at the date of the repurchase mandate. The period prohibiting any new share issuance after these repurchases lasts until 06 December 2025.